title: The good, the bad and the ugly red tape of biomedical research. How could regulators lower bureaucratic hurdles in clinical research without compromising the safety of patients?
authors.forename: Mark
authors.initials: M
authors.lastname: Greener
mesh_terms: D035843:Biomedical Research / Q000331:legislation & jurisprudence* / Q000592:standards; D015316:Genetic Therapy; D006801:Humans; D008004:Licensure; D010344:Patient Advocacy / Q000331:legislation & jurisprudence* / Q000592:standards*; D012449:Safety / Q000331:legislation & jurisprudence* / Q000592:standards; D013234:Stem Cells